Policy-makers are increasingly considering charging users different fees between primary and secondary care (differential user charges) to encourage utilisation of primary health care in health systems with limited gate keeping. A systematic review was conducted to evaluate the impact of introducing differential user charges on service utilisation. We reviewed studies published in MEDLINE, EMBASE, the Cochrane library, EconLIT, HMIC, and WHO library databases from January 1990 until June 2015. We extracted data from the studies meeting defined eligibility criteria and assessed study quality using an established checklist. We synthesized evidence narratively. Eight studies from six countries met our eligibility criteria. The overall study quality was low, with diversity in populations, interventions, settings, and methods. Five studies examined the introduction of or increase in user charges for secondary care, with four showing decreased secondary care utilisation, and three showing increased primary care utilisation. One study identified an increase in primary care utilisation after primary care user charges were reduced. The introduction of a non-referral charge in secondary care was associated with lower primary care utilisation in one study. One study compared user charges across insurance plans, associating higher charges in secondary care with higher utilisation in both primary and secondary care. Overall, the impact of introducing differential user-charges on primary care utilisation remains uncertain. Further research is required to understand their impact as a demand side intervention, including implications for health system costs and on utilisation among low-income patients.
Introduction
Primary health care (PHC) has received renewed prominence by the World Health Organization (World Health Organization 2008) and as part of the United Nations resolution on Universal Health Coverage (UHC) (U.N. General Assembly 2012). Health systems with more developed PHC have better health outcomes, greater financial protection, and improved equity (Atun 2004 , Starfield et al. 2005 , Rasella et al. 2014 , Macinko et al. 2009 , 2010 , attributable to increased comprehensiveness, continuity and coordination of care (Gupta and Bodenheimer 2013 , Pourat et al. 2015 , World Health Organization 2008 , Macinko et al. 2009 ). However, whilst there has been much focus on strengthening PHC, many health systems remain hospital-centric with poorly developed and low quality PHC (Gillam 2008) .
Options for re-orientating health systems towards PHC include gatekeeping -such as in the United Kingdom -where secondary healthcare (SHC) access is restricted without referral from PHC. This may be unfeasible or unacceptable in some settings -especially early on in PHC development when patients expect a choice of providers and direct access to specialists. Other interventions include shifting services from SHC to PHC -such as physically relocating services to the community, or transferring services to the PHC workforce. Without concomitant demand side interventions -such as reducing user fees for PHC or educating patients about the services available -these interventions may be insufficient to alter careseeking behaviour and improve the use of PHC (Sibbald et al. 2007) .
User charges are a powerful tool to alter the demand for healthcare. Research highlights their negative impact on healthcare utilisation, health outcomes, and out of pocket (OOP) expenditure, especially among low-income groups and the poor (Khun and Manderson 2008 , Lagarde and Palmer 2008 , Ridde and Morestin 2011 , Lagarde and Palmer 2011 , Brook et al. 2006 , Chernew and Newhouse 2008 . A number of countries have adopted cost sharing policies that introduced differential user charges to encourage first contact with PHC providers in settings without formal gatekeeping. Differential user charges are OOP expenditures that vary by the service provider type or tier -i.e. between generalist and specialist physicians, or between community and hospital settings for the same service. For example, in Belgium, where patients have free choice of providers, co-payment rates vary between PHC and SHC (Gerkens and Merkur 2010, Biro 2013 ). In Taiwan, where patients also have free choice of provider, 'without referral' co-payments have increased for SHC since 2005. Additionally, in Turkey, a nonreferral co-payment exists for SHC aiming to encourage PHC use (Tatar et al. 2011) . There remains, however, a lack of consensus about whether differential user charges have been successful in incentivising patients to choose PHC providers in the first instance.
We conducted a systematic review to evaluate the impact of differential user charges on PHC service utilisation. Included studies examined either an introduction or increase in a differential user charge between PHC and SHC, and evaluated changes in utilisation of or preference for services. Implied by the term differential user charge, is that a comparator -i.e. a service subjected to lesser or no user charges -is evaluated simultaneously. All retrospective and prospective study designs were included.
Materials and methods

Data sources
The systematic review protocol was registered with the Centre for Reviews and Dissemination at the University of York, UK (http://www.crd.york.ac.uk/PROSPERO/) and included in the PROSPERO database (CRD42014014753). A broad search strategy was employed to maximise sensitivity. The strategy focused on two core domains -'provider choice or healthcare utilization' and 'costsharing' using multiple synonyms. Search strategies are provided in Appendix 1. Searches were conducted between September 2014 and June 2015 for all studies published since January 1990. Six databases in medical and social science literature were searched -MEDLINE, EMBASE, Cochrane library, EconLit, the Health Management Information Consortium (HMIC) database and the WHO library Database (WHOLIS). These findings were supplemented by searching the internet (via Google and Google scholar) and grey literature databases with key terms for additional relevant material. References of articles that met eligibility criteria were also screened for additional studies.
Eligibility criteria
Studies were considered eligible for inclusion if there was the introduction or removal of a differential user charge, which was evaluated quantitatively and over time (i.e. before and after). It was also necessary the study had a 'control/comparator' service (i.e. was not subjected to cost-sharing or at a lesser-rate) that is also evaluated temporally. Studies focusing on healthcare services with predominantly unplanned care, emergency care or specialist services (e.g. pregnancy) were excluded. All populations were considered eligible. Studies in any language, but with English translated titles and abstracts, were considered for inclusion.
Screening and selection
Records were screened based on their title and any relevance to the research questions. The abstracts of selected records were independently reviewed by two authors followed by full article review. Disagreements over inclusion were resolved by two reviewers and where necessary a third.
Data extraction
Data were extracted from each included study by one author and verified by a second. Study characteristics, methods employed, population characteristics, intervention information, statistical techniques, and reported outcomes and conclusions were recorded. Quantitative information regarding the impact of the intervention and statistical results were also recorded.
Quality assessment
Quality was assessed using an adapted checklist from Downs and Black (1998) designed for randomised and non-randomised studies of health care interventions (Downs and Black 1998) . We selected criteria relevant to non-randomised studies supplementing it with our own criteria (Appendix 2). Thirteen questions were used (six relating to reporting, four to internal validity, two to study design and outcome appropriateness, and one to external validity) with studies graded as low (scoring 0-4), intermediate (5-9) and high quality (10-13). Final overall quality grading was revised up or down depending on authors' impressions of issues such as statistical tests and confounding.
Analysis
Due to the large diversity in the institutional setting, study design, intervention type and outcomes measured, meta-analysis was not feasible. Descriptive analysis was performed.
Results
Study selection
35 292 records were obtained, 10 056 duplicates removed, and 25 236 records screened by title. Of these, 271 records were screened by abstract with 53 undergoing full text review. Of these, eight papers were selected for inclusion, with 45 rejected because of the lack of a comparator (most only assessed the changes in one service), 12 due to irrelevant (e.g. emergency care) or qualitative outcomes, 13 due to irrelevant intervention (i.e. there was no difference in the charge), and 5 due to study design limitations (Figure 1 ).
Study characteristics
Of the eight included studies, two were from both Israel (Rosen et al. 2011 , Vardy et al. 2006 and Taiwan (Chen et al. 2009, Huang and Tung 2006) , and one from each of Egypt (Ward 2010) , Eritrea (Asbu 1999) , China (Powell-Jackson et al. 2015) , and the USA (Joyce et al. 2000) (Table 1 ). Most studies (six) were published in 2006 or later, with one (USA) published in 2000 and another (Eritrea) in 1999. Six of the studies were from countries with predominantly insurancefunded health systems, be it public (Israel, Taiwan and China) (Chen et al. 2009 , Huang and Tung 2006 , Powell-Jackson et al. 2015 , Rosen et al. 2011 , Vardy et al. 2006 , or private (USA) (Joyce et al. 2000) . The two studies in Egypt (Ward 2010) and Eritrea (Asbu 1999) were in government run (i.e. not insurance-based) health systems.
Intervention
Six studies (Egypt, Eritrea, Taiwan, USA, and two from Israel) (Asbu 1999 , Huang and Tung 2006 , Joyce et al. 2000 , Rosen et al. 2011 , Vardy et al. 2006 , Ward 2010 ) evaluated the introduction (or in the USA, the continuation) of a higher charge for SHC relative to PHC. One study (Powell-Jackson et al. 2015 ) examined a reduction in charges for PHC in China. Two studies examined the impact of a nonreferral fee for SHC either as part of an increase in user charges (Egypt) (Ward 2010) or as a separate intervention (Taiwan) (Chen et al. 2009 ).
There was considerable variability in the mechanisms through which differential user charges were introduced (including upfront and annual fees, exemptions, and fee gradient across providers), and the size of charges introduced. Study settings and study populations varied spanning community based samples, health service attendees, insurance plans, and the elderly (Table 1) .
For all interventions (except the USA), there was the intention of shifting utilisation from SHC to PHC. Differential user charges were introduced exclusively as a demand-side intervention in all locations except China, where a supply-side reform (changes in provider incentives and payment) was introduced concurrently, but was introduced and evaluated separately.
All studies examined changes in utilisation as the main outcome, with three studies (Asbu 1999 , Powell-Jackson et al. 2015 , Vardy et al. 2006 ) assessing total consultations, two (Rosen et al. 2011) assessing average annual contacts, two (Chen et al. 2009 , Ward 2010 assessing average monthly utilisation, and one (Huang and Tung 2006) assessing changes in provider preference. Additional outcomes examined included changes in medical costs in two studies (Taiwan) (Chen et al. 2009, Huang and Tung 2006) , and preferred provider in one study (Egypt) (Ward 2010) . Stratification was undertaken by demographic subgroups (China) (Powell-Jackson et al. 2015) and selected preventative services (Eritrea) (Asbu 1999 Exclusion criteria: 'lack of comparator' -studies did not measure changes in a similar service that was not subjected to cost-sharing or was at a lesser-rate; 'irrelevant outcomes' -services evaluated were inappropriate (i.e. emergency care); 'irrelevant intervention' -a differential user charge was not introduced; 'study design' -the study did not quantitatively examine the impact of a differential user charge (i.e. the study was hypothetical, was qualitative, or a discussion piece); Annual visits to primary care practitioners and specialists.
Inter-mediate (continued) 
Impact of differential user charge interventions
Of the five studies that evaluated the introduction or increase of user charges in SHC (with lower charges in PHC), four found decreased SHC utilisation, with three studies showing increased PHC utilisation (Table 2) . It was unclear whether associated decreases in SHC attendance led to an increase in attendance to PHC. Two intermediate quality studies (Israel and Taiwan) (Vardy et al. 2006, Huang and Tung 2006) showing lower SHC utilisation, found different effects in PHC, with one (Taiwan) (Huang and Tung 2006) associating differential user charges with increases in PHC utilisation, whilst the other (Israel) (Vardy et al. 2006) with the lower PHC utilisation. Two low quality studies (Egypt and Eritrea) (Ward 2010 , Asbu 1999 ) also associated differential user charges with lower utilisation in SHC and higher utilisation in PHC, but both studies had methodological flaws (potential confounding and unknown population representativeness). In one high quality study (Israel) (Rosen et al. 2011) , the introduction of higher user charges was associated with higher SHC utilisation in three insurance plans, whilst PHC utilisation increased for two insurance schemes, but decreased for one. The USA study (of intermediate quality) which examined the impact of differential user charge arrangements across insurance schemes (Joyce et al. 2000) , found that higher user charges in SHC were associated with higher utilisation in both SHC and PHC. However, increases in PHC utilisation were greater than SHC. There was no adjustment for differences in the characteristics of persons enrolled in the different insurance schemes.
One high quality study (China) (Powell-Jackson et al. 2015) , where user charges for PHC were reduced, showed no significant impact on utilisation patterns in SHC subjected to higher fees. Utilisation in some SHC services increased, but they were not subjected to changes in user charges. Increased utilisation in PHC was associated with reductions in user charges.
One intermediate quality study from Taiwan (Chen et al. 2009 ), evaluating non-referral fee introduction, showed no change in utilisation in SHC, but lower utilisation in PHC services. Notably, the introduction of the non-referral fee coincided with a major clinical audit of physician records, which may have influenced these findings.
Secondary findings
The study in Eritrea (Asbu 1999) reported increases in child immunisation, growth monitoring, family planning, and decreases in primary antenatal care after the introduction of differential user charges. One study (Egypt) (Ward 2010 ) examined patient preferences for health facilities confirming a shift in preferences from SHC to PHC, but also to private services. Both studies (Huang and Tung 2006, Chen et al. 2009) in Taiwan examined costs with one study (Huang and Tung 2006) reporting higher drug use days and total costs per person following differential user charge introduction, whilst the other study (Chen et al. 2009 ) reported lower outpatient costs. The study in China (Powell-Jackson et al. 2015) was the only study that examined potential equity impacts showing that PHC utilisation increased only in the lowest and middle wealth terciles.
Discussion
Our findings suggest the impact of introducing differential usercharges on PHC utilisation remains uncertain. Whilst five of the eight studies suggest differential user charges may have increased utilisation in PHC, two of these were methodologically weak. With regard to SHC utilisation, four (including two low quality) studies found lower utilisation whilst two studies showed increased utilisation in services subjected to higher fees. There is little and very weak evidence that differential user charges can actually shift utilisation from SHC to PHC.
Literature indicates user-charges reduce utilisation, notably in LMICs (Lagarde and Palmer 2011 , Ensor and Ronoh 2005 , Rezayatmand et al. 2013 , whilst utilisation tends to increase following removal and exemption of user charges (Ridde and Morestin 2011, Ensor and Ronoh 2005) (especially for maternal (Dzakpasu et al. 2014 , Hatt et al. 2013 and child health services (Bassani et al. 2013) ). Unfortunately, the literature evaluated in this study was of insufficient quality to determine whether changes in cost altered utilisation patterns. Additionally, there are likely to be other mechanisms beyond cost affecting utilisation including perceived and actual service quality, health literacy, and advice from others (Victoor et al. 2012) . Willingness-to-pay is likely to be influenced by socioeconomics and demographics, and interactions between these, need for healthcare, and characteristics of the services available. These important factors were not considered in any of the studies evaluated, regrettably limiting the ability to identify which aspects beyond cost were influencing the changes reported. Introducing differential user charges per se may be insufficient to achieve behavioural change without further understanding of the factors underpinning provider choice in specific settings, and in the absence of other policies promoting first-contacts in PHC.
Despite the growing enthusiasm (Smullen and Hong 2015, WHO Regional Office for Europe's Health Evidence Network (HEN) 2004) among policy makers for differential user charges to encourage PHC utilisation, we found few high quality studies assessing effectiveness. The context of interventions varied including the quality and availability of services, the extent of pre-existing charges (including existing differentials in cost between PHC and SHC) and patient interactions and satisfaction with different health services. Secondly, the monetary amount of user charges varied both relative to individuals' ability to pay and between services. The generally small differential in user charges implemented between service tiers may explain the modest effects found. Thirdly, there were exemptions from cost-sharing (e.g. due to age or disability), but these were generally not evaluated.
The overall quality of the studies was generally low with methodological flaws, weak statistical tests, inadequate adjustment for confounding, and limited generalizability in terms of populations and services. Most studies did not explicitly test for differences in utilisation change between PHC and SHC. Few studies employed robust quasi-experimental designs which are recommended for evaluating health policy interventions (Petticrew 2009 ). Additionally, Only small number of health centres used, few data points either side of intervention, and potential confounders not controlled for.
China
Powell-Jackson et al. 2015 There was an increase of 47% in usage of village clinics (P<0.05). The effect on township health centre and county hospital usage was nonsignificant. There was reduced utilisation at province hospitals, but no significant impact on inpatient utilisation.
Households in the middle tercile wealth had the largest changes. The largest impact was on individuals living within 1km of village clinic, and on women and migrant workers.
Potential unobserved heterogeneity and confounders Vardy et al. 2006 In hospital outpatient clinics, visits decreased 4.5% after introduction of user charges. New visits and walk-ins declined 6.2% and 10.1% respectively. In community-based specialist clinics (where the user charges were lower) visits decreased 6.8%. These results were in spite of an increase of 2.8% in the health plans members.
Israel
Chronic speciality areas had a higher decrease in total visits (8.5%) and compared to acute speciality (2.3%) in hospital outpatient clinics. In community-based specialists, only acute speciality areas decreased (7.3%).
Differences in types of patients and underlying trends not taken into account. Rosen et al. 2011 In one insurance plan, differential user charges increased utilisation 8% (for those paying user charges compared to exempt group) in common specialities with no significant effect on rare specialties. These results were similar in another insurance plan with an overall effect from user charges increasing total visits 13%, a 20% increase for common specialities and 6% for rare specialities. For the third health plan the effect was converse with a decline of 8% of total visits, a decline of 15% for common specialities and an increase of 3% for rare specialities.
Large differences between health insurance plans are likely. The control population (exempt) is likely to be different and individuals were not always sure of exemption status.
Taiwan
Huang and Tung 2006 The percentage of individuals choosing academic hospitals declined (22.3% after compared to 23.4% prior), with small increases for regional (25.2% from 25.0%), district (14.6% from 14.5%), and clinics (37.9% from 37.1%) (P<0.01). Mean number of visits was lower (11.99 compared to 12.15 visits) after increase in user charges (P<0.001).
After introduction of user charges, drug use days were higher (17.14 compared to 17.06) (P<0.01) and total costs per person were higher (US$39.55 compared to US$35.57) (P<0.01).
Underlying trends not taken into account
(continued) studies did not examine the types of utilisation and whether changes were clinically appropriate. Further research is needed to determine effective interventions for shifting patient demand from SHC to PHC, especially in LMICs. Firstly, robust methodologies are needed for evaluation including quasi-experimental methods that are more appropriate to policyanalysis. Secondly, assessing the impact on quality of care, and clinical and health outcomes is needed. Thirdly, the effectiveness and efficiency of shifting utilisation to PHC need to be assessed, and whether these offset implementation costs of a differential user charge policy. Fourthly, equity remains an issue given the potential for regressive cost-sharing mechanisms not appropriately investigated. Lastly, the untended consequences have not been evaluated, such as for-gone healthcare due to cost.
Strengthening PHC is key for UHC. Differential user charges are being considered in a growing number of settings aiming to promote and encourage PHC utilisation. Our findings show this objective. Other factors influencing PHC utilisation must be considered, including patients' existing preferences for services, and actual and perceived quality of services provided. Further high quality studies are required to determine the impact of differential user charges.
Conclusion
Differential user charges have the potential to encourage greater utilisation of PHC in the absence of formal gatekeeping. However, findings from this systematic review demonstrate there is currently insufficient evidence that their introduction increases first contacts in PHC. Policy makers should exercise caution in implementing differential user charges and plan robust evaluation of impacts, including implications for health equity.
